MainBoardListed
Anthem Biosciences Limited
Company websiteAnthem Biosciences Limited targets ₹5,95,61,404 crore, split as fresh issue ₹0 crore and OFS ₹5,95,61,404 crore.
The offer represents 26 shares. Apply from 14-07-2025 to 16-07-2025. Allotment on 17-07-2025, listing expected on 21-07-2025. Remember: subscription demand will influence listing-day price movements.
Start Date14-07-2025
End Date16-07-2025
Listing Date21-07-2025
Allotment Date17-07-2025
Current Price₹723.05
GMP₹179 (31.40%)
Lot Size26 Shares
Subscription63.89 Times
Face Value₹10 per share
Listing atNSE, BSE
Issue Price₹540 - ₹570
Pre Issue₹55,90,77,100
Post Issue₹0
Issue Size₹5,95,61,404
(aggregating up to 3395.00 Cr)
(aggregating up to 3395.00 Cr)
Fresh Issue
(aggregating up to 0.00 Cr)
(aggregating up to 0.00 Cr)
Offer For Sale₹5,95,61,404
(aggregating up to 3395.00 Cr)
(aggregating up to 3395.00 Cr)
The Grey Market Premium (GMP) for Anthem Biosciences Limited is currently around ₹179 (31.40%). This indicates an estimated listing price of approximately ₹719 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
21 Jul 2025, 04:39 | ₹570 | ₹179 | ₹749 (31.40%) |
19 Jul 2025, 12:40 | ₹570 | ₹155 | ₹725 (27.19%) |
18 Jul 2025, 12:27 | ₹570 | ₹128 | ₹698 (22.46%) |
17 Jul 2025, 12:32 | ₹570 | ₹140 | ₹710 (24.56%) |
16 Jul 2025, 17:33 | ₹570 | ₹144 | ₹714 (25.26%) |
15 Jul 2025, 16:59 | ₹570 | ₹156 | ₹726 (27.37%) |
14 Jul 2025, 12:25 | ₹570 | ₹109 | ₹679 (19.12%) |
12 Jul 2025, 12:27 | ₹570 | ₹94 | ₹664 (16.49%) |
11 Jul 2025, 10:09 | ₹570 | ₹87 | ₹657 (15.26%) |
10 Jul 2025, 12:37 | ₹570 | ₹113 | ₹683 (19.82%) |
09 Jul 2025, 15:06 | ₹570 | ₹96 | ₹666 (16.84%) |
08 Jul 2025, 12:17 | ₹570 | ₹60 | ₹630 (10.53%) |
04 Jul 2025, 04:49 | ₹570 | ₹0 | ₹570 (0.00%) |
02 Jul 2025, 11:43 | ₹570 | ₹0 | ₹570 (0.00%) |
01 Jul 2025, 12:20 | ₹570 | ₹0 | ₹570 (0.00%) |
30 Jun 2025, 09:39 | ₹570 | ₹0 | ₹570 (0.00%) |
Financials overview In Crores
Here is a quick look at the recent financial performance of Anthem Biosciences Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Key Performance
| KPI | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
EPS | 8.04 | 6.48 | 6.75 |
ROE | 20.82 | 20.04 | 24.89 |
ROCE | 26.88 | 25.71 | 31.69 |
RONW | 20.82 | 20.03 | 24.93 |
PRE IPO(PE) | 0 | 0 | 0 |
POST IPO(PE) | 0 | 0 | 0 |
Subscription Demand (in ₹ Crore)
| Category | Offered | Demand | Times |
|---|---|---|---|
QIBs | ₹677.35 | 130592.47 | 192.80 |
RETAIL | ₹1,185.36 | 7059.33 | 5.96 |
NIB | ₹508.01 | 22712.77 | 44.71 |
HNIs 2+ | ₹169.34 | 5218.41 | 30.82 |
HNIs 10+ | ₹338.68 | 17494.36 | 51.65 |
EMPLOYEES | ₹9.04 | 63.31 | 7.00 |
Total | ₹2,379.77 | 160427.88 | 67.41 |
Application Wise Breakup (Approx. no of Apps)
| Category | Reserved | Applied | Times |
|---|---|---|---|
RETAIL | 7,99,840 | 47,63,378 | 5.96 |
HNIs(10L +) | 16,323 | 8,43,183 | 51.66 |
HNIs (2-10L) | 8,162 | 2,51,514 | 30.82 |
Total | 8,24,325 | 58,58,075 | 7.11 |
The IPO reservation for Anthem Biosciences Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
Retail | 49.81% | 2,07,95,833 |
NII(HNI) | 21.34% | 89,12,500 |
QIB | 28.46% | 1,18,83,334 |
Employees | 0.39% | 1,58,654 |
TOTAL | 100.00% | 4,17,50,321 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail | 1 | 26 | ₹14,820 | |
sHNI | 14 | 364 | ₹2,07,480 | |
bHNI | 68 | 1,768 | ₹10,07,760 |
Below you can find the official contact details of Anthem Biosciences Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: investors.abl@anthembio.com
Phone: +91 080 6672 400
Website: https://www.anthembio.com/
Address: No. 49, F1 & F2, Canara Bank Road Bommasandra Industrial Area, Phase 1, Bommasandra, Bengaluru, Karnataka, 560099